These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation. Peters SMB; Mink MCT; Privé BM; de Bakker M; de Lange F; Muselaers CHJ; Mehra N; Witjes JA; Gotthardt M; Nagarajah J; Konijnenberg MW EJNMMI Res; 2023 Jan; 13(1):6. PubMed ID: 36692682 [TBL] [Abstract][Full Text] [Related]
6. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT. Gosewisch A; Ilhan H; Tattenberg S; Mairani A; Parodi K; Brosch J; Kaiser L; Gildehaus FJ; Todica A; Ziegler S; Bartenstein P; Böning G EJNMMI Res; 2019 Aug; 9(1):76. PubMed ID: 31414241 [TBL] [Abstract][Full Text] [Related]
9. Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer. Kabasakal L; AbuQbeitah M; Aygün A; Yeyin N; Ocak M; Demirci E; Toklu T Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1976-83. PubMed ID: 26227531 [TBL] [Abstract][Full Text] [Related]
12. Comparison of different methods for post-therapeutic dosimetry in [ Rosar F; Schön N; Bohnenberger H; Bartholomä M; Stemler T; Maus S; Khreish F; Ezziddin S; Schaefer-Schuler A EJNMMI Phys; 2021 May; 8(1):40. PubMed ID: 33950333 [TBL] [Abstract][Full Text] [Related]
13. Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry. Uijen MJM; Privé BM; van Herpen CML; Westdorp H; van Gemert WA; de Bakker M; Gotthardt M; Konijnenberg MW; Peters SMB; Nagarajah J Nucl Med Commun; 2023 Apr; 44(4):270-275. PubMed ID: 36597884 [TBL] [Abstract][Full Text] [Related]
14. Dosimetry of Violet J; Jackson P; Ferdinandus J; Sandhu S; Akhurst T; Iravani A; Kong G; Kumar AR; Thang SP; Eu P; Scalzo M; Murphy D; Williams S; Hicks RJ; Hofman MS J Nucl Med; 2019 Apr; 60(4):517-523. PubMed ID: 30291192 [No Abstract] [Full Text] [Related]
15. Dosimetry and safety of Paganelli G; Sarnelli A; Severi S; Sansovini M; Belli ML; Monti M; Foca F; Celli M; Nicolini S; Tardelli E; Marini I; Matteucci F; Giganti M; Di Iorio V; De Giorgi U Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3008-3017. PubMed ID: 32430583 [TBL] [Abstract][Full Text] [Related]
16. Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T. Brosch-Lenz J; Uribe C; Gosewisch A; Kaiser L; Todica A; Ilhan H; Gildehaus FJ; Bartenstein P; Rahmim A; Celler A; Ziegler S; Böning G EJNMMI Phys; 2021 Mar; 8(1):26. PubMed ID: 33709253 [TBL] [Abstract][Full Text] [Related]
17. Quantitative imaging for Meyer C; Szidonya L; Winters C; Mench A; Mallak N; Mittra E Front Nucl Med; 2023; 3():1291253. PubMed ID: 39355047 [TBL] [Abstract][Full Text] [Related]
18. Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after Völter F; Mittlmeier L; Gosewisch A; Brosch-Lenz J; Gildehaus FJ; Zacherl MJ; Beyer L; Stief CG; Holzgreve A; Rübenthaler J; Cyran CC; Böning G; Bartenstein P; Todica A; Ilhan H Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33802417 [TBL] [Abstract][Full Text] [Related]
19. Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using Mahmoudi E; Pirayesh E; Deevband MR; Amoui M; Rad MG; Ghorbani M Nucl Med Mol Imaging; 2021 Oct; 55(5):237-244. PubMed ID: 34721716 [TBL] [Abstract][Full Text] [Related]
20. Determination of Critical Organ Doses with Yilidir G; Demir M J Med Phys; 2024; 49(2):304-310. PubMed ID: 39131436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]